These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7801960)

  • 1. Diagnosis of hypertensive end-stage renal disease: effect of patient's race.
    Perneger TV; Whelton PK; Klag MJ; Rossiter KA
    Am J Epidemiol; 1995 Jan; 141(1):10-5. PubMed ID: 7801960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association between race and incidence of end-stage renal disease secondary to glomerulonephritis: influence of the histologic type and presence of arterial hypertension].
    Lopes AA; Silveira MA; Martinelli RP; Rocha H
    Rev Assoc Med Bras (1992); 2001; 47(1):78-84. PubMed ID: 11340455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial differences in the incidence of end-stage renal disease.
    Tell GS; Hylander B; Craven TE; Burkart J
    Ethn Health; 1996 Mar; 1(1):21-31. PubMed ID: 9395545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting racial differences in ESRD due to ADPKD in the United States.
    Murphy EL; Dai F; Blount KL; Droher ML; Liberti L; Crews DC; Dahl NK
    BMC Nephrol; 2019 Feb; 20(1):55. PubMed ID: 30764782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?
    Whittle JC; Whelton PK; Seidler AJ; Klag MJ
    Arch Intern Med; 1991 Jul; 151(7):1359-64. PubMed ID: 2064486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher protein intake is associated with increased risk for incident end-stage renal disease among blacks with diabetes in the Southern Community Cohort Study.
    Malhotra R; Cavanaugh KL; Blot WJ; Ikizler TA; Lipworth L; Kabagambe EK
    Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1079-1087. PubMed ID: 27562875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical correlates of hypertensive end-stage renal disease.
    Bleyer AJ; Chen R; D'Agostino RB; Appel RG
    Am J Kidney Dis; 1998 Jan; 31(1):28-34. PubMed ID: 9428448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors.
    Brancati FL; Whittle JC; Whelton PK; Seidler AJ; Klag MJ
    JAMA; 1992 Dec; 268(21):3079-84. PubMed ID: 1433738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endstage renal disease owing to diabetic nephropathy in Mississippi: an examination of factors influencing renal survival in a population prone to late referral.
    Crook ED; Harris J; Oliver B; Fleischman E; Crenshaw G; Taylor R
    J Investig Med; 2001 May; 49(3):284-91. PubMed ID: 11352187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. History of hypertension in patients treated for end-stage renal disease.
    Perneger TV; Whelton PK; Klag MJ
    J Hypertens; 1997 Apr; 15(4):451-6. PubMed ID: 9211180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of hypertension on the incidence of end-stage renal disease in negroes and mulattoes with glomerulonephritis].
    Lopes AA; Silveira MA; Martinelli R; Noblat AC
    Rev Assoc Med Bras (1992); 2002; 48(2):167-71. PubMed ID: 12205536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Race, socioeconomic status, and the development of end-stage renal disease.
    Byrne C; Nedelman J; Luke RG
    Am J Kidney Dis; 1994 Jan; 23(1):16-22. PubMed ID: 8285192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002.
    Stewart JH; McCredie MR; Williams SM; Jager KJ; Trpeski L; McDonald SP;
    Nephrology (Carlton); 2007 Oct; 12(5):520-7. PubMed ID: 17803478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiology of end-stage renal disease in Georgia.
    McClellan W; Brogan D
    J Med Assoc Ga; 1990 Mar; 79(3):153-6. PubMed ID: 2319217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of end-stage renal disease in overseas-born, compared with Australian-born, non-indigenous Australians.
    Stewart JH; McCredie MR; McDonald SP
    Nephrology (Carlton); 2004 Aug; 9(4):247-52. PubMed ID: 15363057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial differences in the incidence of end-stage renal disease in types I and II diabetes mellitus.
    Stephens GW; Gillaspy JA; Clyne D; Mejia A; Pollak VE
    Am J Kidney Dis; 1990 Jun; 15(6):562-7. PubMed ID: 2368696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension.
    McClellan W; Tuttle E; Issa A
    Am J Kidney Dis; 1988 Oct; 12(4):285-90. PubMed ID: 3263042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertensive end-stage renal disease in blacks: the role of end-stage renal disease surveillance.
    McClellan W
    Am J Kidney Dis; 1993 Apr; 21(4 Suppl 1):25-30. PubMed ID: 8465832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial factors in the incidence and causation of end-stage renal disease (ESRD).
    Easterling RE
    Trans Am Soc Artif Intern Organs; 1977; 23():28-33. PubMed ID: 910346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher risk for renal failure in first-degree relatives of white patients with end-stage renal disease: a population-based study.
    O'Dea DF; Murphy SW; Hefferton D; Parfrey PS
    Am J Kidney Dis; 1998 Nov; 32(5):794-801. PubMed ID: 9820449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.